STOCK TITAN

Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) will report its financial results for Q1 2022 on April 28, 2022, after the market closes. A conference call to discuss these results is scheduled for 3 PM PT (6 PM ET). The company, a leader in life science research and clinical diagnostics, had revenues of $2.9 billion in 2021 and has been operational since 1952, serving a global customer base focused on advancing healthcare.

Positive
  • None.
Negative
  • None.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2022 on Thursday, April 28, 2022, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.

To listen, call 844-200-6205 within the U.S. or 929-526-1599 outside the U.S., access code: 493268. You may also listen to the conference call live via webcast that is available on the "Investor Relations" section of our website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 7,900 employees worldwide. Bio-Rad had revenues of $2.9 billion in 2021. For more information, please visit bio-rad.com.

Bio-Rad Laboratories, Inc.

Edward Chung, Vice President, Investor Relations

510-741-6104

ir@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

FAQ

When will Bio-Rad announce its Q1 2022 financial results?

Bio-Rad will announce its Q1 2022 financial results on April 28, 2022.

What time is the Bio-Rad Q1 2022 earnings conference call?

The conference call for Bio-Rad's Q1 2022 earnings will take place at 3 PM Pacific Time on April 28, 2022.

How can I listen to the Bio-Rad earnings call?

You can listen to the Bio-Rad earnings call by calling 844-200-6205 in the U.S. or 929-526-1599 outside the U.S., or through the webcast available on their Investor Relations website.

What were Bio-Rad's revenues in 2021?

Bio-Rad reported revenues of $2.9 billion for the year 2021.

Bio-Rad Laboratories, Inc.

NYSE:BIO

BIO Rankings

BIO Latest News

BIO Stock Data

9.18B
19.42M
15.58%
80.03%
1.87%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
HERCULES